http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2512344-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_769d70a24b147e303a353e9b4f14d58d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 1981-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90762d417a5d3a19bbce07ae5fc4725c
publicationDate 1983-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2512344-A1
titleOfInvention PROCESS FOR THE PRODUCTION OF A STABLE SUSPENSION OF ALUMINUM HYDROXIDE AND / OR MAGNESIA HYDROXIDE AS ACTIVE AGENT OF ANTACIDA
abstract THE PROCESS FOR MANUFACTURING A STABLE SUSPENSION OF HYDROXIDE OF ALUMINA AND OR HYDROXIDE OF MAGNESIA AS AN ACTIVE AGENT IN ANTACIDA CONSISTS OF MIXING HYDROXIDE OF ALUMINA AND OR OF MAGNESIA POWDER, WITH WATER, AND A FRAGMENT AND MECHANICALLY DISPERSED THIS MIXTURE UNTIL AN AVERAGE SIZE OF PARTICLES OF THE ORDER OF 5 TO 10M IS OBTAINED. THE DISPERSION IS CARRIED OUT IN A HOMOGENEIZER, UNDER HIGH PRESSURE BETWEEN 50 AND 500KGCM. THE PRODUCT IS INTENDED TO BE INTRODUCED IN MEDICINAL PRODUCTS FOR THE TREATMENT OF GASTRIC HYPERACIDITY.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9413304-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9413304-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5631026-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5455050-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0286978-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9421268-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5874112-A
priorityDate 1981-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1126105-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449196400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14792
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10176082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46878358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451818717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID170190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453694953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453459427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9989226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452381074

Total number of triples: 39.